Bavarian Nordic ADR (BVNRY)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
7.8150 +0.0650 (+0.84%) 04/29/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 7.8150 unch (unch) 13:38 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | BVNRY | ARWR | TVTX | ||
| Company | Bavarian Nordic ADR | Arrowhead Pharma | Travere Therapeutics Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 7.8100 | 13.49 | 19.36 | ||
| High | 7.8150 | 13.82 | 20.08 | ||
| Low | 7.7800 | 13.29 | 19.11 | ||
| Last | 7.8150 | 13.47 | 20.08 | ||
| Change | +0.0650 | -0.05 | +0.72 | ||
| % Change | +0.84% | -0.37% | +3.72% | ||
| Volume | 4,200 | 1,112,800 | 1,175,800 | ||
| 20-Day Average Volume | 5,060 | 2,119,980 | 1,833,230 | ||
| Previous Close | 7.7500 | 13.52 | 19.36 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 7.4174 | 12.07 | 16.05 | ||
| 20-Day Raw Stochastic | 100.00% | 91.12% | 99.93% | ||
| 20-Day Relative Strength | 53.18% | 48.16% | 59.49% | ||
| Weighted Alpha | -21.56 | -55.47 | +170.84 | ||
| Today's Opinion | 64% Sell | 88% Sell | 40% Buy | ||
| Previous Opinion | 72% Sell | 88% Sell | 40% Buy | ||
| Last Month's Opinion | 100% Sell | 100% Sell | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.18% since 04/22/25 | +8.98% since 04/22/25 | +26.45% since 04/22/25 | ||
| Low | 7.6000 on 04/23/25 | 12.76 on 04/23/25 | 16.18 on 04/23/25 | ||
| High | 7.8150 on 04/29/25 | 13.85 on 04/28/25 | 20.08 on 04/29/25 | ||
| 1-Month | |||||
| %Chg | +2.42% since 03/28/25 | -2.53% since 03/28/25 | +2.03% since 03/28/25 | ||
| Low | 6.5950 on 04/07/25 | 9.57 on 04/07/25 | 12.91 on 04/09/25 | ||
| High | 7.8150 on 04/29/25 | 13.85 on 04/28/25 | 20.08 on 04/29/25 | ||
| 3-Month | |||||
| %Chg | -12.78% since 01/29/25 | -32.48% since 01/29/25 | -1.81% since 01/29/25 | ||
| Low | 6.5950 on 04/07/25 | 9.57 on 04/07/25 | 12.91 on 04/09/25 | ||
| High | 9.3200 on 01/30/25 | 21.84 on 02/07/25 | 25.29 on 02/11/25 | ||
| 6-Month | |||||
| %Chg | -25.22% since 10/29/24 | -32.58% since 10/29/24 | +9.31% since 10/29/24 | ||
| Low | 6.5950 on 04/07/25 | 9.57 on 04/07/25 | 12.91 on 04/09/25 | ||
| High | 10.6710 on 10/30/24 | 27.34 on 11/29/24 | 25.29 on 02/11/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,848,756 | 1,849,660 | 1,782,542 | ||
| Shares Outstanding, K | 236,565 | 137,317 | 88,772 | ||
| Annual Sales | 828,850,000 | 3,550,000 | 233,180,000 | ||
| Annual Net Income | 143,260,000 | -599,490,000 | -321,550,000 | ||
| Last Quarter Sales | 300,840,000 | 2,500,000 | 74,790,000 | ||
| Last Quarter Net Income | 111,850,000 | -173,090,000 | -60,260,000 | ||
| 60-Month Beta | 1.55 | 0.99 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.47 on 03/05/25 | -1.39 on 02/10/25 | -0.73 on 02/20/25 | ||
| Latest Earnings Date | 05/14/25 | 05/08/25 | 05/01/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 12.92 | 0.00 | 0.00 | ||